Regis Healthcare (ASX:REG) Return-on-Tangible-Equity: Negative Tangible Equity% (As of Dec. 2025)


ASX:REG Regis Healthcare Ltd ASX:REG
84 GF Score
Price A$6.51
GF Value A$10.49
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Regis Healthcare Return-on-Tangible-Equity?

Regis Healthcare ASX:REG 84 Return-on-Tangible-Equity is Negative Tangible Equity% as of Dec. 2025. GuruFocus rates ASX:REG with a GF Score™ of 84/100 and a GF Value™ of A$10.49 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 581 Healthcare Providers & Services companies, Regis Healthcare ranks better than 99.83% on this metric.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Regis Healthcare's annualized net income for the quarter that ended in Dec. 2025 was A$27 Mil. Regis Healthcare's average shareholder tangible equity for the quarter that ended in Dec. 2025 was A$-569 Mil. Therefore, Regis Healthcare's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was Negative Tangible Equity%.

The historical rank and industry rank for Regis Healthcare's Return-on-Tangible-Equity or its related term are showing as below:

ASX:REG' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: Negative Tangible Equity

ASX:REG's Return-on-Tangible-Equity is ranked better than
99.83% of 581 companies
in the Healthcare Providers & Services industry
Industry Median: 9.93 vs ASX:REG: Negative Tangible Equity

Regis Healthcare  (ASX:REG) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Regis Healthcare Return-on-Tangible-Equity Related Terms


Regis Healthcare Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for Regis Healthcare's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regis Healthcare Return-on-Tangible-Equity Chart

Regis Healthcare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only Negative Tangible Equity 0.00 0.00 0.00 Negative Tangible Equity

Regis Healthcare Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 Negative Tangible Equity Negative Tangible Equity Negative Tangible Equity

ASX:REG vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison

For the Medical Care Facilities subindustry, Regis Healthcare's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regis Healthcare Return-on-Tangible-Equity vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Regis Healthcare's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Regis Healthcare's Return-on-Tangible-Equity falls into.


ASX:REG
84GF Score
Regis Healthcare Ltd ASX:REG
Return-on-Tangible-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regis Healthcare Return-on-Tangible-Equity Calculation

Regis Healthcare's annualized Return-on-Tangible-Equity for the fiscal year that ended in Jun. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=48.951/( (-386.223+-439.966 )/ 2 )
=48.951/-413.0945
=Negative Tangible Equity %

Regis Healthcare's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=26.888/( (-439.966+-698.8)/ 2 )
=26.888/-569.383
=Negative Tangible Equity %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of Negative Tangible Equity% mean?
Regis Healthcare (ASX:REG) has a Return-on-Tangible-Equity of Negative Tangible Equity% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Regis Healthcare and its competitors. According to the industry distribution chart, Regis Healthcare ranks #1 out of 581 companies in the Healthcare Providers & Services industry, placing it in the top 0.2%.
Is Regis Healthcare's Return-on-Tangible-Equity too high?
Regis Healthcare's current Return-on-Tangible-Equity is Negative Tangible Equity%. Based on the distribution chart, Regis Healthcare ranks #1 out of 581 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Regis Healthcare has a GF Score™ of 84/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Regis Healthcare's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Regis Healthcare ranks #1 out of 581 companies for Return-on-Tangible-Equity. This places Regis Healthcare in the top 0% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 9.93. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 9.93, based on 581 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Regis Healthcare and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 9.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Regis Healthcare's current Return-on-Tangible-Equity is Negative Tangible Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Regis Healthcare (ASX:REG) is currently considered Possible Value Trap. The stock's GF Value™ is A$10.49, compared to a current price of A$6.51 — trading 37.9% below its estimated fair value. The current Return-on-Tangible-Equity is Negative Tangible Equity%. Regis Healthcare's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Regis Healthcare (ASX:REG), the current Return-on-Tangible-Equity is Negative Tangible Equity% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Regis Healthcare (ASX:REG) Overvalued in 2026?

Based on GuruFocus' analysis, Regis Healthcare stock appears to be undervalued. The current stock price of A$6.51 is trading 37.9% below its estimated GF Value™ of A$10.49. GuruFocus considers Regis Healthcare to be Possible Value Trap.

Key valuation signals for ASX:REG:

  • Return-on-Tangible-Equity: Negative Tangible Equity%
  • GF Value™: A$10.49 vs. price of A$6.51 (37.9% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the ASX:REG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Regis Healthcare Business Description

Other Exchanges 06K1:Germany
Address 293 Camberwell Road, Level 2, Camberwell, Melbourne, VIC, AUS, 3124
Regis Healthcare is an Australian residential aged care operator providing accommodation and care for individuals who require high levels of support due to health or mobility issues. Residents are typically over 85 years old and are typified by dementia, palliative care, incontinence, and falls risk. Regis also operates smaller retirement village and home care businesses.
84GF Score

Get the complete analysis for ASX:REG

Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$6.51
Price
A$10.49
GF Value